Metabian Metabian is a European pharmaceutical company and is based in France, Spain and Romania. Our business is registering, promoting, and marketing pharmaceutical products in the operating markets, facilitating the linkage between global companies to get access to Mena markets. Despite providing a wide range of product profiles ourselves, European companies can be offered access to the fast developing market of the Mena market via Metabian on the basis of mutual interest.
We aim to lead access to safe, high-quality medicines across Europe through regulatory excellence and a patient-first approach.
We are driven by a deep commitment to patient well-being, regulatory excellence, and cross-border collaboration. With a focus on quality, innovation, and integrity, we strive to deliver trusted pharmaceutical solutions that meet Europe’s highest standards.
Our mission is to provide high-end pharmaceutical brands of exceptional quality, grounded in scientific research and guided by our core principle: “Access to Quality Healthcare.”
Quality Assurance
Standard
Every product bearing the Metabian brand is put through a stringent quality process and is delivered in complete compliance with European standards
Commitment
Metabian can meet and maintain the highest standards, which are essential to our brand promise, because of our consistent dedication to safety, efficacy and quality.
Diligence
We fervently and devotedly follow the most stringent legal criteria, making sure that quality always comes first—for the benefit of each and every patient we treat.
Focused on addressing critical healthcare needs.
International Network
Our quick expansion and the creation of a diverse portfolio with more than 120 products are the results of our strategic focus on emerging markets.
Metabian is committed to forming strategic alliances across the globe. We work with regional partners to distribute and advertise premium branded and generic medications. We are forging a solid presence in quickly developing areas like the Middle East, Africa, Southeast Asia, the CIS, and Latin America.
Metabian's purpose is supported locally, regionally, and globally by our team in sales, marketing, regulatory affairs, quality assurance, supply chain management, finance, and international sales.
The company’s portfolio is designed to target pressing medical conditions, with a strong emphasis on women’s health, anti-infective treatments, pain management, cardiovascular health, metabolic disorders, and central nervous system diseases.
Metabian specializes in the acquisition and commercialization of European-manufactured generic medicines across a diverse range of therapeutic areas.
Metabian ensures that its products meet the highest standards of safety and efficacy developed and manufactured exclusively in Europe, serving international markets.
What We Do
Partner
Metabian provides a cooperative strategy at close range and is your reliable partner in branded and generic pharmaceutical development and marketing.
Compassion
By determining particular medical needs, providing medicines manufactured in the EU with well-researched at reasonable costs, and making sure they get to the people who need them the most, we complete the cycle.
Partnership
Under the Metabian brand, we provide comprehensive solutions and strategies that put accessibility and patient care first.
Metabian is a European pharmaceutical company and a marketing authorization holder in Europe, with addresses strategically located in France, Spain, and Romania.
With a commitment to innovation and affordability, The Company plays a crucial role in improving patient access to essential medications while fostering sustainable growth in the generic pharmaceutical industry.
Its presence in key European locations positions the company to respond effectively to international healthcare demands and regulatory landscapes, driving its mission of advancing health outcomes globally.
Global Concerns
Gastroesophageal Reflux Disease (GERD) in Adolescents and Its Link to Modern Lifestyles
Gastroesophageal Reflux Disease (GERD) in Adolesce...
Read More >>
Hypertension: The Silent Threat to Global Health
Hypertension: The Silent Threat to Global Health I...
Read More >>
Hyperthyroidism: Global Prevalence, Systemic Implications, and Modern Management
Hyperthyroidism: Global Prevalence, Systemic Impli...
Read More >>
Obesity and Its Association with Endocrine Disorders: A Growing Metabolic Crisis
Obesity and Its Association with Endocrine Disorde...
Read More >>
Diabetes Mellitus: A Global Health Emergency and Its Systemic Impact
Diabetes Mellitus: A Global Health Emergency and I...
Read More >>
Autism Spectrum Disorder (ASD) and Attention-Deficit/Hyperactivity Disorder (ADHD): A Global Neurodevelopmental Challenge
Autism Spectrum Disorder (ASD) and Attention-Defic...
Read More >>